116 related articles for article (PubMed ID: 7925857)
1. Stimulus-specific defect in platelet aggregation in polycythemia vera.
Le Blanc K; Berg A; Palmblad J; Samuelsson J
Eur J Haematol; 1994 Sep; 53(3):145-9. PubMed ID: 7925857
[TBL] [Abstract][Full Text] [Related]
2. Impaired platelet binding of fibrinogen due to a lower number of GPIIB/IIIA receptors in polycythemia vera.
Le Blanc K; Lindahl T; Rosendahl K; Samuelsson J
Thromb Res; 1998 Sep; 91(6):287-95. PubMed ID: 9772010
[TBL] [Abstract][Full Text] [Related]
3. Further studies of the defective stimulus-response coupling for the oxidative burst in neutrophils in polycythemia vera.
Samuelsson J; Berg A
Eur J Haematol; 1991 Oct; 47(4):239-45. PubMed ID: 1954981
[TBL] [Abstract][Full Text] [Related]
4. Studies of neutrophil and monocyte oxidative responses in polycythaemia vera and related myeloproliferative disorders.
Samuelsson J; Forslid J; Hed J; Palmblad J
Br J Haematol; 1994 Jul; 87(3):464-70. PubMed ID: 7993785
[TBL] [Abstract][Full Text] [Related]
5. Defective platelet aggregation in polycythaemia vera is not caused by impaired calcium signaling, phospholipase D activation or decreased amounts of focal adhesion proteins.
Le Blanc K; Berg A; Palmblad J; Samuelsson J
Eur J Haematol; 2000 Nov; 65(5):322-30. PubMed ID: 11092463
[TBL] [Abstract][Full Text] [Related]
6. Impaired activation of phospholipase D in polycythaemia vera-implications for the pathogenesis of the disease?
Samuelsson J
Leuk Lymphoma; 1995 Sep; 19(1-2):21-6. PubMed ID: 8574168
[TBL] [Abstract][Full Text] [Related]
7. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.
Panova-Noeva M; Marchetti M; Russo L; Tartari CJ; Leuzzi A; Finazzi G; Rambaldi A; ten Cate H; Falanga A
Thromb Res; 2013 Jul; 132(1):88-93. PubMed ID: 23735588
[TBL] [Abstract][Full Text] [Related]
8. 1-O-hexadecyl-2-metoxy-glycero-3-phosphatidylcholine--a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxidative metabolism.
Le Blanc K; Samuelsson J; Brohult J; Berg A; Palmblad J
Biochem Pharmacol; 1995 May; 49(11):1577-82. PubMed ID: 7786298
[TBL] [Abstract][Full Text] [Related]
9. Superoxide anion production and phospholipase D-mediated generation of diacylglycerol are subnormal after N-formyl-methionyl-leucyl-phenylalanine stimulation of polymorphonuclear granulocytes in polycythemia vera.
Samuelsson J; Hansson A; Rosendahl K; Palmblad J
J Lab Clin Med; 1993 Feb; 121(2):310-9. PubMed ID: 8381848
[TBL] [Abstract][Full Text] [Related]
10. Stimulus-specific defect in oxidative metabolism of polymorphonuclear granulocytes in polycythemia vera.
Samuelsson J; Lindström P; Palmblad J
Eur J Haematol; 1988 Nov; 41(5):454-8. PubMed ID: 2850216
[TBL] [Abstract][Full Text] [Related]
11. Effects of plumbagin on platelet aggregation and platelet-neutrophil interactions.
Shen Z; Dong Z; Cheng P; Li L; Chen Z; Liu J
Planta Med; 2003 Jul; 69(7):605-9. PubMed ID: 12898414
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet function by polymorphonuclear leukocytes.
Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
[TBL] [Abstract][Full Text] [Related]
13. A novel thrombopoietin signaling defect in polycythemia vera platelets.
Moliterno AR; Siebel KE; Sun AY; Hankins WD; Spivak JL
Stem Cells; 1998; 16 Suppl 2():185-92. PubMed ID: 11012190
[TBL] [Abstract][Full Text] [Related]
14. Role of platelet-activating factor (PAF) in superoxide production by human polymorphonuclear leukocytes.
Takahashi S; Yoshikawa T; Naito Y; Tanigawa T; Yoshida N; Kondo M
Lipids; 1991 Dec; 26(12):1227-30. PubMed ID: 1668119
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation.
Presseizen K; Friedman Z; Shapiro H; Radnay J; Ellis MH
Clin Appl Thromb Hemost; 2002 Jan; 8(1):33-9. PubMed ID: 11991237
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of phorbol ester-induced protein kinase activity in human neutrophils by platelet-activating factor.
Gay JC; Stitt ES
J Cell Physiol; 1988 Dec; 137(3):439-47. PubMed ID: 3192624
[TBL] [Abstract][Full Text] [Related]
17. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism.
Sisson JH; Prescott SM; McIntyre TM; Zimmerman GA
J Immunol; 1987 Jun; 138(11):3918-26. PubMed ID: 3035016
[TBL] [Abstract][Full Text] [Related]
18. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
Ostermann G; Till U; Thielmann K
Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
[TBL] [Abstract][Full Text] [Related]
19. Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapy.
Tselepis AD; Goudevenos JA; Tambaki AP; Michalis L; Stroumbis CS; Tsoukatos DC; Elisaf M; Sideris DA
Cardiovasc Res; 1999 Jul; 43(1):183-91. PubMed ID: 10536703
[TBL] [Abstract][Full Text] [Related]
20. Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin.
Lauri D; Cerletti C; de Gaetano G
Agents Actions; 1986 Mar; 17(5-6):506-11. PubMed ID: 3706054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
